90101-16-9

90101-16-9 structure

Name: 5-Methyl-3-(pyridin-2-yl)benzo[5,6][1,2]thiazino[3,4-e][1,3]oxazine-2,4(3H,5H)-dione 6,6-dioxide
Chemical Name: droxicam
CAS Number: 90101-16-9
Molecular Formula: C₁₆H₁₁N₃O₅S
Molecular Weight: 357.34
Catalog: API Antipyretic analgesics Non-steroidal anti-inflammatory drugs
Create Date: 2018-09-29 23:02:33
Modify Date: 2024-01-08 14:51:49
Droxicam (Ombolan) is a non-steroidal anti-inflammatory agent, with strong analgesic activity. Droxicam acts by inhibiting PGE2 varies, and is characterised by being a pro-drug of Piroxicam (HY-B0253). Droxicam is well tolerated with slight side effects in the said mucosa. Droxicam does not show cardiovascular or respiratory effects in cats, and inhibits peritoneal capillary permeability in mouse[1][2].

Name	droxicam
Synonyms	Droxicam 2H,5H-1,3-Oxazino[5,6-c][1,2]benzothiazine-2,4(3H)-dione, 5-methyl-3-(2-pyridinyl)-, 6,6-dioxide 5-methyl-6,6-dioxo-3-pyridin-2-yl-[1,3]oxazino[5,6-c][1,2]benzothiazine-2,4-dione 5-Methyl-3-(2-pyridinyl)-2H,5H-[1,3]oxazino[5,6-c][1,2]benzothiazine-2,4(3H)-dione 6,6-dioxide 5-Methyl-3-(pyridin-2-yl)-2H,5H-[1,3]oxazino[5,6-c][1,2]benzothiazine-2,4(3H)-dione 6,6-dioxide Ombolan 5-Methyl-3-(2-pyridinyl)-2H,5H-1,3-oxazino[5,6-c][1,2]benzothiazine-2,4(3H)-dione 6,6-Dioxide 5-Methyl-3-(pyridin-2-yl)benzo[5,6][1,2]thiazino[3,4-e][1,3]oxazine-2,4(3H,5H)-dione 6,6-dioxide

Description	Droxicam (Ombolan) is a non-steroidal anti-inflammatory agent, with strong analgesic activity. Droxicam acts by inhibiting PGE2 varies, and is characterised by being a pro-drug of Piroxicam (HY-B0253). Droxicam is well tolerated with slight side effects in the said mucosa. Droxicam does not show cardiovascular or respiratory effects in cats, and inhibits peritoneal capillary permeability in mouse[1][2].
Related Catalog	Signaling Pathways >> Others >> Others Research Areas >> Inflammation/Immunology
In Vivo	Droxicam (0.25 和 0.5 mg/kg；口服) 在角叉菜胶诱导的大鼠水肿中表现出高抗炎活性[1]。 Droxicam (ED50, p.o.; 5, 6, 7, 8 h; 7.5, 12.9, 4.8, 8.4 mg/kg) 在大鼠中对制霉菌素诱导的水肿表现出高抗炎活性[1]。 Droxicam (ED50，口服，1、2、3、4 小时：0.51、0.94、1.56、4.88 mg/kg) 对紫外线光诱导红斑的豚鼠，显示出保护作用[1]。 Droxicam (0.1 mg/kg, 0.33 mg/kg, 1 mg/kg; po; 每日一次) 在注射 Mycobacterium butyricum 的大鼠中显示出良好的抗关节炎活性，可抵抗原发性和继发性病变[1]。 Droxicam 在防止小鼠扭体方面表现出很强的镇痛活性，对由苯基苯醌诱导、乙酰胆碱溴化物诱导的小鼠，ED50 分别为 5.3 mg/kg 和 1.1 mg/kg[1]。 Droxicam (ED50=0.081 mg/kg; po) 保护大鼠免受蓖麻油引起的腹泻[1]。 Droxicam 显著抑制小鼠腹膜毛细血管通透性[1]。 Droxicam 在 Irwin 试验中，不会改变大鼠的行为 (80 mg/kg，i.p.) 和小鼠的行为 (160 mg/kg，p.o.)[1]。 Droxicam 在大鼠中不表现出排尿酸活性，在麻醉猫中既不表现出心血管或呼吸作用，也不改变它们对乙酰胆碱、去甲肾上腺素和组胺给药的反应[1]。
References	[1]. Farré AJ, et al. Pharmacological properties of droxicam, a new non-steroidal anti-inflammatory agent. Methods Find Exp Clin Pharmacol. 1986 Jul;8(7):407-22. [2]. Jané F, et al. Droxicam: a pharmacological and clinical review of a new NSAID. Eur J Rheumatol Inflamm. 1991;11(4):3-9.

Density	1.7±0.1 g/cm3
Boiling Point	554.7±60.0 °C at 760 mmHg
Melting Point	259-261°
Molecular Formula	C₁₆H₁₁N₃O₅S
Molecular Weight	357.34
Flash Point	289.3±32.9 °C
Exact Mass	357.041931
PSA	110.86000
LogP	1.11
Vapour Pressure	0.0±1.5 mmHg at 25°C
Index of Refraction	1.748

CHEMICAL IDENTIFICATION

RTECS NUMBER :: RP6505000

CHEMICAL NAME :: 2H,5H-1,3-Oxazino(5,6-c)(1,2)benzothiazine-2,4(3H)-di one, 5-methyl-3-(2-pyridinyl)-, 6,6-dioxide

CAS REGISTRY NUMBER :: 90101-16-9

LAST UPDATED :: 199612

DATA ITEMS CITED :: 2

MOLECULAR FORMULA :: C16-H11-N3-O5-S

MOLECULAR WEIGHT :: 357.36

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 1434 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #4563452

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 6192 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #4563452

32315-10-9

36322-90-4

~83%

90101-16-9

Literature: Bracher, Franz; Berns, Caroline Journal fur Praktische Chemie - Chemiker - Zeitung, 1997 , vol. 339, # 5 p. 477 - 478

Precursor 2
32315-10-9 36322-90-4
DownStream 0

1158522-08-7	940364-43-2
134104-43-1	131615-57-1
6906-52-1	930439-75-1
1018584-77-4	1375289-11-4
849349-65-1	127437-46-1